+ Filter



EXOC8 Q656P

Anti-EXOC8 Q656P ProductsBackground
Anti-EXOC8 Q656P Products
- Human Anti-EXOC8 Q656P Recombinant Soluble TCR (clone MEL218) (scTCR-0379YC-S(P))
-
- Epitope: IILVAVPHV
- MHC: HLA-A*02:01
-
- Epitope: IILVAVPHV
- MHC: HLA-A*02:01
- Recombinant Human Anti-EXOC8 Q656P Soluble TCR (MEL218) (C-Cys) (VS-0622-YF4388)
-
- Epitope: IILVAVPHV
- MHC: HLA-A*02:01
- Recombinant Human Anti-EXOC8 Q656P Soluble TCR (MEL218) (KIH) (VS-0622-YF7096)
-
- Epitope: IILVAVPHV
- MHC: HLA-A*02:01
View More Products
Can't find the products you're looking for? Try to filter in the left sidebar.Filter By Tag
More Infomation
Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us
For Research Use Only. Not For Clinical Use.
Background
TMEM48 F169L, SEC24A P469L, and EXOC8 Q656P represent dominant antigens as T cell immunity was detected prior to vaccination (naturally occurring) and these neoantigens are processed and presented from endogenously expressed protein. TKT R438W, CDKN2A E153K, AKAP13 Q285K and PABPC1 R520Q are characterized as subdominant antigens as T cell immunity required peptide vaccination and these neoantigens are processed and presented from endogenously expressed protein.